C-type lectin-like molecule 1 (CLL-1) is an AML-associated antigen that has garnered researchers’ attention because it is preferentially expressed on AML stem cells and blasts while being absent on normal hematopoietic stem cells [89]. This evidence concerns the gene CLEC12A and acute myeloid leukemia.